CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 9 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baader Bank Aktiengesellschaft | 12,916 | $1,415 | 0.00% |
| UBS Group AG | 29,870 | $3,674 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 105,039 | $12 | 0.00% |
| Citadel Advisors | 191,339 | $23,535 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 49,965 | $6,146 | 0.00% |
| HRT FINANCIAL LP | 48,507 | $5 | 0.00% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 42,771 | $5,261 | 0.00% |
| Qube Research & Technologies Ltd | 50 | $6 | 0.00% |